← Evidence map

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

Osimertinib plus Ramucirumab: The Best of Both Worlds?

Edward B GaronPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 33334907